<DOC>
	<DOC>NCT01333397</DOC>
	<brief_summary>The primary objective is to assess the dose response versus placebo of a single treatment of Dysport RU (Dysport RU, Ready to Use, for injection), for the improvement in appearance of moderate to severe glabellar lines at maximum frown.</brief_summary>
	<brief_title>Safety and Efficacy Study of Dysport RU and Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Female between 30 60 years of age Moderate to severe vertical glabellar lines at maximum frown at baseline Silicone injections into the upper face Any prior treatment with fillers (e.g. collagentype implants) skin abrasions or photorejuvenation within the previous 12 months Any planned facial cosmetic surgery during the study period A history of ablative skin resurfacing of the area to be treated during the study.</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>